SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is experiencing significant upward momentum as investors brace for the imminent 80th event milestone in its Phase 3 REGAL trial, which serves as a major catalyst for potential top-line results and buyout speculation. The stock is currently being driven by an intense short squeeze environment, characterized by extreme borrowing costs and high institutional engagement, fueling strong bullish sentiment among community members focused on the company's long-term oncology potential.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

Ouster is trending as investors aggressively rotate into physical AI and robotics infrastructure, bolstered by a new strategic supply agreement to equip AI-powered heavy machinery. The community is focused on Ouster's transition into a unified perception platform, with bullish sentiment driven by its multi-layered sensing stack and the broader secular expansion of autonomous technologies.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid is experiencing significant volatility driven by market speculation around a potential short squeeze, fueled by high borrow rates and heavy short interest. While retail investors are debating the long-term outlook of its robotaxi partnerships and cost-cutting measures, the stock's price action remains a major point of contention regarding institutional influence and sector-wide sentiment.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is experiencing a strong surge driven by heavy retail call buying and a perceived relief rally, with community members actively debating whether the move is a sustainable breakout or a classic options-driven 'pump' that risks a sharp reversal. Investors are balancing excitement over potential deliveries and future AI initiatives against ongoing concerns regarding high volatility, valuation, and the influence of institutional rebalancing.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckin Coffee is currently trending as retail investors express intense frustration over the stock's stagnant price action and lack of progress toward a potential NASDAQ relisting. While many in the community remain vocal about the company's strong fundamental store growth and store expansion, discussions are dominated by cynicism regarding management's communication, the impact of the ongoing share buyback program, and the disparity in performance compared to broader market trends.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is currently trending due to reports of a raid on its Taiwan offices by authorities investigating alleged chip smuggling, which has fueled widespread community debate over corporate governance and potential regulatory risks. While some investors interpret the volatility as a coordinated short-selling tactic to shake out shareholders ahead of future earnings, others are expressing significant frustration with management, viewing the ongoing probes as a sign of deeper operational instability.

AeroVironment, Inc. is a defense technology company delivering integrated capabilities across air, land, sea, space, and cyber. The company develops and deploys autonomous systems, loitering munitions, counter-UAS technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities-built to meet the mission needs of today’s warfighter and tomorrow’s conflicts. At the core of these technologies lies AV_Halo, a modular, mission-ready suite of AI-powered software tools that empowers warfighters and enables full-battlefield dominance: detect, decide, deliver. With a national manufacturing footprint and a deep innovation pipeline, AV delivers proven systems and future-defining capabilities at speed, scale, and operational relevance. The company was founded by Paul B. MacCready, Jr. in July 1971 and is headquartered in Arlington, VA.

AeroVironment Inc.

AeroVironment is currently trending as investors weigh the company's significant long-term growth potential in the drone and defense robotics sector against recent volatility caused by accounting restatements and concerns over contract execution. Market sentiment remains divided, with the community actively debating whether current price levels offer a compelling entry point for a sector leader ahead of upcoming earnings and future defense budget cycles.

Jack in the Box, Inc. engages in the provision of developing, operating, and franchising a chain of quick-service and fast-casual restaurants. It operates through the Jack in the Box and Del Taco segments. The Jack in the Box segment offers a selection of distinctive products including classic burgers and other product lines such as Buttery Jack Burgers. The company was founded by Robert Oscar Peterson in 1951 and is headquartered in San Diego, CA.

Jack In The Box, Inc.

Jack in the Box is seeing intense community debate over its potential as a short squeeze candidate, with investors highlighting its low float and high short interest compared to sector peers. While some traders are betting on a turnaround fueled by debt-reduction plans and potential acquisition interest, others remain cautious due to declining sales, high debt levels, and mixed sentiment regarding the company's long-term competitive position in the fast-food market.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as shareholders navigate uncertainty regarding an upcoming FDA advisory committee meeting and ongoing legal disputes, while simultaneously anticipating the release of long-term trial data. Investors remain focused on the potential for a dual-label approval to validate the drug's efficacy and long-term durability in Duchenne muscular dystrophy treatment.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is seeing a surge in investor interest and trading volume as the company initiates a Phase 1 clinical trial for its novel obesity drug, VK3019, fueling speculation about potential partnerships or acquisition interest from major pharmaceutical players. The community is actively discussing the stock's significant relative strength against broader market trends, with bulls optimistic about upcoming clinical readouts and a potential short squeeze as they closely monitor institutional buying patterns and long-term pipeline potential.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Sensus Healthcare Reports First Quarter 2026 Financial Results and Business Highlights

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company committed to providing highly effective, non-invasive treatments for oncological and non-oncological skin conditions, today announced financial results and business highlights for the three months ended March 31, 2026. Highlights...

Sensus Healthcare (SRTS) Projected to Post Earnings on Thursday

Sensus Healthcare (NASDAQ:SRTS) will be releasing its Q1 2026 earnings after the market closes on Thursday, May 7. (View Earnings Report at...

Sensus Healthcare (NASDAQ:SRTS) Shares Pass Below 50-Day Moving Average   - Here's Why

Sensus Healthcare (NASDAQ:SRTS) Stock Passes Below Fifty Day Moving Average - Time to Sell...

Sensus Healthcare to Report First Quarter 2026 Financial Results and Hold Business Update Conference Call on May 7, 2026

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company committed to providing highly effective, non-invasive treatments for oncological and non-oncological skin conditions, today announced...

Sensus Healthcare, Inc. (NASDAQ:SRTS) Receives Average Rating of "Moderate Buy" from Analysts

Sensus Healthcare, Inc. (NASDAQ:SRTS - Get Free Report) has earned a consensus rating of "Moderate Buy" from the six ratings firms that are covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and four have assigned...

Sensus Healthcare, Inc. (NASDAQ:SRTS) Short Interest Update

Sensus Healthcare, Inc. (NASDAQ:SRTS - Get Free Report) saw a large decrease in short interest in March. As of March 13th, there was short interest totaling 394,950 shares, a decrease of 18.3% from the February 26th total of 483,655 shares. Currently, 2.6% of the company's shares are sold short...

Sensus Healthcare, Inc. (NASDAQ:SRTS) Given Consensus Rating of "Moderate Buy" by Analysts

Shares of Sensus Healthcare, Inc. (NASDAQ:SRTS - Get Free Report) have been given an average rating of "Moderate Buy" by the six analysts that are currently covering the firm, MarketBeat.com reports...

Sensus Healthcare Files Lawsuit Against SkinCure Oncology for Breach of Contract

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, today announced the filing of a lawsuit in the Circuit Court for the Fifteenth...

Sensus Healthcare (NASDAQ:SRTS) Now Covered by Analysts at Alliance Global Partners

Alliance Global Partners started coverage on Sensus Healthcare in a research report on Friday. They set a "buy" rating and a $7.50 price target for the company...

Sensus Healthcare Introduces Sensus Link, Brings Advanced Operating Capabilities to the SRT-100 Installed Base

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological...

Sensus Healthcare, Inc. is a medical device company, which engages in the provision of treatment for both oncological and non-oncological skin conditions. The company was founded by Joseph C. Sardano, Richard Golin, Kalman Fishman, and Stephen Cohen on May 7, 2010 and is headquartered in Boca Raton, FL.

Sensus Healthcare Inc

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$3.06
Prev Close	$3.04
Open	$2.95
Dividend Yield	0.00%
50-Day Moving Average	$3.35
Beta	0.80
Avg. Volume	93,678.04
PE Ratio	-6.40

52-Week High	$5.92
52-Week Low	$2.66
Market Capitalization	$50.04M
EPS (Annual)	-$0.4728
Price to Book	1.10
Revenue Per Employee	$458,033.33

Feed

News

Sentiment

Earnings

Fundamentals

Info

SRTSSensus Healthcare Inc

Latest SRTS News